Literature DB >> 24845042

Feasibility of linking population-based cancer registries and cancer center biorepositories.

Margaret E McCusker1, Rosemary D Cress, Mark Allen, Allyn Fernandez-Ami, Regina Gandour-Edwards.   

Abstract

PURPOSE: Biospecimen-based research offers tremendous promise as a way to increase understanding of the molecular epidemiology of cancers. Population-based cancer registries can augment this research by providing more clinical detail and long-term follow-up information than is typically available from biospecimen annotations. In order to demonstrate the feasibility of this concept, we performed a pilot linkage between the California Cancer Registry (CCR) and the University of California, Davis Cancer Center Biorepository (UCD CCB) databases to determine if we could identify patients with records in both databases.
METHODS: We performed a probabilistic data linkage between 2180 UCD CCB biospecimen records collected during the years 2005-2009 and all CCR records for cancers diagnosed from 1988-2009 based on standard data linkage procedures.
RESULTS: The 1040 UCD records with a unique medical record number, tissue site, and pathology date were linked to 3.3 million CCR records. Of these, 844 (81.2%) were identified in both databases. Overall, record matches were highest (100%) for cancers of the cervix and testis/other male genital system organs. For the most common cancers, matches were highest for cancers of the lung and respiratory system (93%), breast (91.7%), and colon and rectum (89.5%), and lower for prostate (72.9%).
CONCLUSIONS: This pilot linkage demonstrated that information on existing biospecimens from a cancer center biorepository can be linked successfully to cancer registry data. Linkages between existing biorepositories and cancer registries can foster productive collaborations and provide a foundation for virtual biorepository networks to support population-based biospecimen research.

Entities:  

Mesh:

Year:  2012        PMID: 24845042      PMCID: PMC4076995          DOI: 10.1089/bio.2012.0014

Source DB:  PubMed          Journal:  Biopreserv Biobank        ISSN: 1947-5543            Impact factor:   2.300


  8 in total

1.  Procurement of population-based cancer tissue in Iowa.

Authors:  C F Lynch; J A Kutza; S L Kelley; C E Platz
Journal:  Mod Pathol       Date:  1999-04       Impact factor: 7.842

2.  Ensuring quality in studies linking cancer registries and biobanks.

Authors:  Hilde Langseth; Tapio Luostarinen; Freddie Bray; Joakim Dillner
Journal:  Acta Oncol       Date:  2010-04       Impact factor: 4.089

Review 3.  Biomarkers in cancer epidemiology: an integrative approach.

Authors:  Paolo Boffetta
Journal:  Carcinogenesis       Date:  2009-12-03       Impact factor: 4.944

4.  Tissues from population-based cancer registries: a novel approach to increasing research potential.

Authors:  Marc T Goodman; Brenda Y Hernandez; Stephen Hewitt; Charles F Lynch; Timothy R Coté; Henry F Frierson; Christopher A Moskaluk; Jeffrey L Killeen; Wendy Cozen; Charles R Key; Limin Clegg; Marsha Reichman; Benjamin F Hankey; Brenda Edwards
Journal:  Hum Pathol       Date:  2005-07       Impact factor: 3.466

5.  Nordic biological specimen banks as basis for studies of cancer causes and control--more than 2 million sample donors, 25 million person years and 100,000 prospective cancers.

Authors:  Eero Pukkala; Aage Andersen; Göran Berglund; Randi Gislefoss; Vilmundur Gudnason; Göran Hallmans; Egil Jellum; Pekka Jousilahti; Paul Knekt; Pentti Koskela; P Pentti Kyyrönen; Per Lenner; Tapio Luostarinen; Arthur Löve; Helga Ogmundsdóttir; Pär Stattin; Leena Tenkanen; Laufey Tryggvadóttir; Jarmo Virtamo; Göran Wadell; Anders Widell; Matti Lehtinen; Joakim Dillner
Journal:  Acta Oncol       Date:  2007       Impact factor: 4.089

6.  A multidisciplinary approach to honest broker services for tissue banks and clinical data: a pragmatic and practical model.

Authors:  Rajiv Dhir; Ashok A Patel; Sharon Winters; Michelle Bisceglia; Dennis Swanson; Roger Aamodt; Michael J Becich
Journal:  Cancer       Date:  2008-10-01       Impact factor: 6.860

7.  Cancer surveillance research.

Authors:  William F Anderson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-06       Impact factor: 4.254

Review 8.  Molecular pathology in epidemiologic studies: a primer on key considerations.

Authors:  Mark E Sherman; Will Howatt; Fiona M Blows; Paul Pharoah; Stephen M Hewitt; Montserrat Garcia-Closas
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-03-23       Impact factor: 4.254

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.